4-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile, 95.0%, 5g

3-(3-Methoxyphenyl)-3-oxo-propionic acid methylester, 95.0%, 5g

DL-Homocystine, 95.0%, 10g

(4R,4'R)-1,1'-Bis(3-(tert-butyl)phenyl)-4,4'-dicyclohexyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 100mg

7-bromo-3H,4H-pyrido[3,4-d]pyridazin-4-one, 95%, 1g

Methyl 2-(6-amino-4-oxo-3,4-dihydroquinazolin-3-yl)acetate, 95%, 1g

Methyl 2,6-difluoro-3-nitrobenzoate, 95.0%, 10g

7-Chloroisoquinoline-1-carboxylic acid, 95.0%, 1g

Nickel nitrate matrix modifier solution, 10 g/l Ni(NO3)2, (99.999%) in 1% HNO3

Sodium-2-naphthol-7-sulfonate, 98.0%, 100g

4-(2-oxo-1,2-dihydropyridin-1-yl)butanoic acid, 95.0%, 250mg

3-Amino-4-(1H-pyrazol-1-yl)benzoic acid, 95%, 5g

2-Methoxy-5-nitroaniline, 95.0%, 500g